Dec 10, 2012
(CIDRAP News) – The US Food and Drug Administration (FDA) yesterday approved the nation's first cell-based flu vaccine, a product from Novartis that uses technology that could help vaccinate more Americans in a pandemic but still has many of the same limitations of older egg-based flu vaccines.
(CIDRAP News) – A government advisory committee yesterday endorsed the safety and immunogenicity of an adjuvant-containing H5N1 influenza vaccine proposed for inclusion in the US pandemic emergency stockpile, signaling that it could become the first adjuvanted flu vaccine to win approval in the United States.
Oct 22, 2012
Oct 18, 2012
The world needs much better influenza vaccines, but the quest for them faces a formidable barrier: overconfidence about the effectiveness of existing influenza vaccines.
Editor’s Note: This article covers research conducted by CIDRAP scientists. Please note that CIDRAP News operates independently in relation to CIDRAP's research and policy programs.
Oct 5, 2012
(CIDRAP News) – US influenza policy experts who gathered in Washington, DC, today called for better vaccines and other steps for improving pandemic and seasonal flu preparedness, themes echoed in an action plan released by the Infectious Diseases Society of America (IDSA).
(CIDRAP News) – The US Department of Health and Human Services (HHS) recently awarded a new round of contracts to the five US-licensed influenza vaccine manufacturers to make pre-pandemic and pandemic influenza vaccines—projects that could be worth billions of dollars if another pandemic arises in the next few years.
